SPSAF yields 4.31% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, SPSAF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SPSAF + JNJ for your $10,000?
Sopra Steria Group SA provides consulting, digital, and software development services in France and internationally. The company operates through five segments: France, United Kingdom, Other Europe, Sopra Banking Software, and Other Solutions. It offers consulting services, including business and technology consulting services for large companies and public bodies; systems integration services that covers information system lifecycle and transformation programs; and cybersecurity services. The company also provides software for banks and financial institutions, human resources, and property management; business process services; and IT infrastructure management services, as well as lending solutions. It serves customers in the retail, energy and utilities, financial services, government and public sector, transport, aerospace, defense and security, insurance, telecommunication, media and entertainment, and other industries. Sopra Steria Group SA was incorporated in 1968 and is headquartered in Paris, France.
Full SPSAF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.